# Hepatocellular Carcinoma Treated With Iodine-125 Implantation

> **NCT01717729** · PHASE3 · COMPLETED · sponsor: **The Second People's Hospital of GuangDong Province** · enrollment: 136 (actual)

## Conditions studied

- Liver Carcinoma

## Interventions

- **PROCEDURE:** Radiofrequency Ablation
- **RADIATION:** iodine

## Key facts

- **NCT ID:** NCT01717729
- **Lead sponsor:** The Second People's Hospital of GuangDong Province
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2012-08
- **Final completion:** 2012-10
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2012-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01717729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01717729, "Hepatocellular Carcinoma Treated With Iodine-125 Implantation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01717729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*